FDA post-approval expectations for adventitious virus contamination prevention.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):698-712. doi: 10.5731/pdajpst.2011.00846.
PDA J Pharm Sci Technol. 2011.
PMID: 22294604